Acute Effect of Continuous Positive Airway Pressure in Heart Failure
Sponsored by UPECLIN HC FM Botucatu Unesp
About this trial
Last updated 10 years ago
Study ID
upeclin/HC/FMB-Unesp-30
Status
Completed
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 15 years ago
What is this trial about?
Acute effects of CPAP on diastolic function in patients with compensated heart failure (CHF)
are unknown. The investigators hypothesized that acutely CPAP improves diastolic function,
which is associated with increases exercise tolerance.
Objective: To evaluate the acute effects of CPAP on functional capacity and diastolic indices
of patients with CHF. This is a randomized trial including 44 patients with compensated heart
failure (functional classes II or III, NYHA). Patients will be allocated in CPAP(CPAP with
10cmH2O) or simulated CPAP (null pressure) after computed randomization, in a 1:1 ratio. All
subjects shall complete a 6-minute walk test (6MWT) before and after CPAP (30 minutes; 10 cm
H2O pressure). Doppler-echocardiogram will be performed before and at the end of CPAP.
Wilcoxon or paired t tests were used to compare results, with significance level at p < 0.05.
What are the participation requirements?
Inclusion Criteria
- functional class II or III (NYHA)heart failure
- agreement to participate in the study
- absence of acute exacerbation of dyspnea
- intact upper airway
Exclusion Criteria
- valvular heart disease
- chest pain or unstable angina
- acute myocardial infarction in the prior month
- uncontrolled hypertension
- atrial fibrillation or other arrhythmias
- acute infection
- orthopedic limitations
- intolerance to CPAP mask